Latest filing published 11 May 2023 for Acadia Healthcare Company, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Laurence L. Harrod: trading record in brief
Laurence L. Harrod (chief executive) discloses dealings in Acadia Healthcare Company, Inc. to SEC (Form 4). Between 14 August 2019 and 9 May 2023, the trades on record add up to 16 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 11 May 2023 came the latest disclosure, a share grant in Acadia Healthcare Company, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Laurence L. Harrod
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,954 shares0Common StockSEC:0000950170-23-021421:0
- 512 shares@ US$73.716.9% of flowCommon StockSEC:0000899243-23-011668:0
- 439 shares@ US$73.275.9% of flowCommon StockSEC:0000950170-23-012738:0
- 2,600 shares@ US$69.4433.4% of flowCommon StockSEC:0000899243-23-009735:0
- 191,301 shares0Common StockSEC:0000899243-23-006015:0
- 1,034 shares@ US$82.6116.7% of flowCommon StockSEC:0000899243-22-028818:0
- 512 shares@ US$68.016.5% of flowCommon StockSEC:0000899243-22-015687:0
- 4,466 shares0Common StockSEC:0000899243-22-014749:0
- 2,600 shares@ US$64.4830.6% of flowCommon StockSEC:0000899243-22-012366:0
- 55,761 shares0Common StockSEC:0000899243-22-008404:0
10 of 10 declarations
